Enhanced COPD Management in Suspected Lung Cancer Patients

Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates. This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle. The findings could inform clinical practice by emphasizing the i

Trial Details

NCT ID
NCT07543601
Phase
NA
Sponsor
Ditte Krag-Hansen
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Tailored COPD consultations
Locations (sample)
  • Vejle, Denmark|55.70927,9.5357

Key Eligibility Criteria

  • Undergoing diagnostic evaluation for suspected lung cancer
  • Spirometry showing obstructive airflow limitation (FEV₁/FVC \< 75 % or FEV₁ \< 80 %, and no reversibility) at the first outpatient visit at the lun…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →